SHBG and metabolic dysfunction-associated steatotic liver disease: This underscores the potential use of SHBG as a molecular marker for early identification of individuals with high odds of NAFLD (Saez-Lopez et al., 2017; Sáez-López et al., 2019; Sarkar et al., 2019).